MARC details
| 000 -LEADER |
|---|
| fixed length control field |
03743cam a2200421Mi 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
ocn785777976 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20240726105329.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
120227s2012 enka ob 001 0 eng d |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
E7B |
| Language of cataloging |
eng |
| Description conventions |
pn |
| -- |
rda |
| Transcribing agency |
E7B |
| Modifying agency |
OCLCQ |
| -- |
YDXCP |
| -- |
CUS |
| -- |
OCLCQ |
| -- |
NT |
| -- |
IDEBK |
| -- |
CDX |
| -- |
OCLCA |
| -- |
OCLCF |
| -- |
DEBSZ |
| -- |
DA |
| -- |
EBLCP |
| -- |
UKDOC |
| -- |
OCLCQ |
| -- |
AGLDB |
| -- |
OCLCQ |
| -- |
STF |
| -- |
VTS |
| -- |
REC |
| -- |
AU@ |
| -- |
OCLCQ |
| -- |
LEAUB |
| -- |
AJS |
| -- |
DKU |
| -- |
OCLCO |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781848166295 |
| Qualifying information |
|
| 050 04 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
QP519 |
| Item number |
.A585 2012 |
| 049 ## - LOCAL HOLDINGS (OCLC) |
|---|
| Holding library |
MAIN |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Antibody drug discovery /Clive R. Wood, editor. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
London : |
| Name of publisher, distributor, etc. |
Imperial College Press, |
| Date of publication, distribution, etc. |
(c)2012. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
1 online resource (xv, 473 pages) : |
| Other physical details |
illustrations (some color) |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
computer |
| Media type code |
c |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
online resource |
| Carrier type code |
cr |
| Source |
rdacarrier |
| 347 ## - DIGITAL FILE CHARACTERISTICS |
|---|
| File type |
data file |
| Source |
rda |
| 490 1# - SERIES STATEMENT |
|---|
| Series statement |
Molecular medicine and medicinal chemistry ; |
| Volume # |
v. 4 |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Includes bibliographies and index. |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Ch. 1. Humanization of antibodies / |
| Statement of responsibility |
Olivier Leger and Jose W. Saldanha -- |
| Title |
chapter 2. Selection and screening of antibody phage display libraries / |
| Statement of responsibility |
David R. Buckler [and others] -- |
| Title |
chapter 3. Affinity maturation approaches for antibody lead optimization / |
| Statement of responsibility |
David Lowe, Trevor Wilkinson and Tristan J. Vaughan -- |
| Title |
chapter 4. Transgenic mice rearranging human antibodies / |
| Statement of responsibility |
Sean Stevens -- |
| Title |
chapter 5. Isotype selection and Fc engineering: design and construction of fit-for-purpose therapeutic antibodies / |
| Statement of responsibility |
William R. Strohl -- |
| Title |
chapter 6. Antibody expression from bacteria to transgenic animals / |
| Statement of responsibility |
Paul Stephens and Berni M. Sweeney -- |
| Title |
chapter 7. Current trends in antibody purification and lead selection / |
| Statement of responsibility |
Jie Chen and Andrew Nixon -- |
| Title |
chapter 8. Design and application of immunoconjugates for cancer therapy / |
| Statement of responsibility |
Sherif El Sheikh [and others] -- |
| Title |
chapter 9. Dual-targeting bispecific antibodies as new therapeutic modalities for cancer / |
| Statement of responsibility |
Zhenping Zhu -- |
| Title |
chapter 10. Antibody fragments and alternate protein scaffolds / |
| Statement of responsibility |
Lioudmila Tchistiakova [and others. |
| 520 0# - SUMMARY, ETC. |
|---|
| Summary, etc. |
Monoclonal antibodies have become important treatments for cancer, inflammation and a wide range of other diseases, representing an increasing share of the most successful pharmaceutical markets. The technologies to discover these drugs have been developed by select centers of excellence in industry and academia, and are continually being fine tuned in the race to identify the best antibody-based drug candidates and accelerate their paths to patients. The objective of this volume is to provide a series of guides to those evaluating and preparing to enter particular areas within the field and to offer specialized perspectives to established researchers. The chapters set into context the significance of key developments and important considerations for selecting different approaches, such as antibody humanization, isotype selection, lead candidate selection criteria and protein production. All contributors to this work are experts in their fields and many have played pivotal roles in the creation of these technologies. |
| 530 ## - COPYRIGHT INFORMATION: |
|---|
| COPYRIGHT INFORMATION |
COPYRIGHT NOT covered - Click this link to request copyright permission: |
| Uniform Resource Identifier |
<a href="b">b</a> |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Immunoenzyme technique. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Antibody-drug conjugates. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Immunology |
| General subdivision |
Technique. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Drug development. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Pharmaceutical biotechnology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Immunoglobulins. |
| 655 #1 - INDEX TERM--GENRE/FORM |
|---|
| Genre/form data or focus term |
Electronic Books. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Wood, Clive R. |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href="https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=516762&site=eds-live&custid=s3260518">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=516762&site=eds-live&custid=s3260518</a> |
| -- |
Click to access digital title | log in using your CIU ID number and my.ciu.edu password |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Koha item type |
Online Book (LOGIN USING YOUR MY CIU LOGIN AND PASSWORD) |
| DONATED BY: |
|
| VENDOR |
EBSCO |
| Classification part |
QP.. |
| PUBLICATION YEAR |
2012 |
| LOCATION |
ONLINE |
| REQUESTED BY: |
|
| -- |
|
| -- |
NFIC |
| Source of classification or shelving scheme |
|
| 994 ## - |
|---|
| -- |
92 |
| -- |
NT |
| 902 ## - LOCAL DATA ELEMENT B, LDB (RLIN) |
|---|
| a |
1 |
| b |
Cynthia Snell |
| c |
1 |
| d |
Cynthia Snell |